Sweet Financial Partners, LLC Amgen Inc Transaction History

Sweet Financial Partners, LLC

$447 Million
Q3 2024

A detailed history of Sweet Financial Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Sweet Financial Partners, LLC holds 8,307 shares of AMGN stock, worth $2.19 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

8,307

Previous 9,179 9.5%

Holding current value

$2.19 Million

Previous $2.87 Million 6.66%

% of portfolio

0.6%

Previous 0.68%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$309.38 - $337.38 $269,779 - $294,195	-872 Reduced 9.5%	8,307 $2.68 Million
Q2 2024 Jul 18, 2024	SELL	$262.75 - $319.31 $6,043 - $7,344	-23 Reduced 0.25%	9,179 $2.87 Million
Q1 2024 Apr 23, 2024	SELL	$268.87 - $324.56 $1.13 Million - $1.37 Million	-4,212 Reduced 31.4%	9,202 $2.62 Million
Q4 2023 Jan 12, 2024	BUY	$255.7 - $288.46 $71,340 - $80,480	279 Added 2.12%	13,414 $3.86 Million
Q3 2023 Oct 23, 2023	BUY	$218.65 - $271.46 $51,382 - $63,793	235 Added 1.82%	13,135 $3.53 Million
Q2 2023 Jul 24, 2023	BUY	$214.27 - $253.37 $662,951 - $783,926	3,094 Added 31.55%	12,900 $2.86 Million
Q1 2023 Apr 14, 2023	BUY	$225.79 - $275.2 $932,964 - $1.14 Million	4,132 Added 72.82%	9,806 $2.37 Million
Q4 2022 Jan 19, 2023	SELL	$229.03 - $291.01 $9,161 - $11,640	-40 Reduced 0.7%	5,674 $0
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $387,866 - $437,443	-1,728 Reduced 23.22%	5,714 $1.29 Million
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $579,312 - $644,674	2,511 Added 50.92%	7,442 $1.81 Million
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $331,097 - $366,280	1,510 Added 44.14%	4,931 $1.19 Million
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $680,368 - $778,619	3,421 New	3,421 $770,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sweet Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sweet Financial Partners, LLC with notifications on news.

Account

Sweet Financial Partners, LLC Amgen Inc Transaction History